
iRhythm Technologies, Inc. (IRTC)
IRTC Stock Price Chart
Explore iRhythm Technologies, Inc. interactive price chart. Choose custom timeframes to analyze IRTC price movements and trends.
IRTC Company Profile
Discover essential business fundamentals and corporate details for iRhythm Technologies, Inc. (IRTC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
20 Oct 2016
Employees
2.00k
Website
https://www.irhythmtech.comCEO
Quentin S. Blackford
Description
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
IRTC Financial Timeline
Browse a chronological timeline of iRhythm Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.01, while revenue estimate is $219.32m.
Earnings released on 30 Apr 2026
EPS came in at -$0.43 surpassing the estimated -$0.56 by +23.21%, while revenue for the quarter reached $199.39m , beating expectations by +2.72%.
Earnings released on 19 Feb 2026
EPS came in at $0.17 surpassing the estimated $0.02 by +750.00%, while revenue for the quarter reached $208.89m , beating expectations by +3.46%.
Earnings released on 30 Oct 2025
EPS came in at -$0.06 surpassing the estimated -$0.36 by +83.33%, while revenue for the quarter reached $192.88m , missing expectations by -4.42%.
Earnings released on 31 Jul 2025
EPS came in at -$0.32 surpassing the estimated -$0.53 by +39.62%, while revenue for the quarter reached $186.69m , beating expectations by +6.36%.
Earnings released on 1 May 2025
EPS came in at -$0.95 falling short of the estimated -$0.89 by -6.74%, while revenue for the quarter reached $158.68m , beating expectations by +3.45%.
Earnings released on 20 Feb 2025
EPS came in at $0.01 surpassing the estimated -$0.29 by +103.45%, while revenue for the quarter reached $164.33m , beating expectations by +3.81%.
Earnings released on 30 Oct 2024
EPS came in at -$1.26 falling short of the estimated -$0.55 by -129.09%, while revenue for the quarter reached $147.54m , missing expectations by -6.22%.
Earnings released on 1 Aug 2024
EPS came in at -$0.61 surpassing the estimated -$0.92 by +33.70%, while revenue for the quarter reached $148.05m , beating expectations by +1.26%.
Earnings released on 2 May 2024
EPS came in at -$1.47 falling short of the estimated -$0.99 by -48.48%, while revenue for the quarter reached $131.93m , beating expectations by +2.74%.
Earnings released on 22 Feb 2024
EPS came in at -$1.26 falling short of the estimated -$0.60 by -110.00%, while revenue for the quarter reached $132.51m , beating expectations by +1.75%.
Earnings released on 2 Nov 2023
EPS came in at -$0.89 falling short of the estimated -$0.65 by -36.92%, while revenue for the quarter reached $124.60m , beating expectations by +1.66%.
Earnings released on 3 Aug 2023
EPS came in at -$0.61 surpassing the estimated -$0.75 by +18.67%, while revenue for the quarter reached $124.13m , beating expectations by +3.15%.
Earnings released on 4 May 2023
EPS came in at -$1.29 falling short of the estimated -$0.80 by -61.25%, while revenue for the quarter reached $111.44m , beating expectations by +4.10%.
Earnings released on 23 Feb 2023
EPS came in at -$0.67 falling short of the estimated -$0.63 by -6.35%, while revenue for the quarter reached $112.62m , beating expectations by +2.14%.
Earnings released on 1 Nov 2022
EPS came in at -$0.63 surpassing the estimated -$0.82 by +23.17%, while revenue for the quarter reached $103.88m , missing expectations by -1.88%.
Earnings released on 4 Aug 2022
EPS came in at -$0.79 surpassing the estimated -$0.94 by +15.96%, while revenue for the quarter reached $102.05m , beating expectations by +1.69%.
Earnings released on 5 May 2022
EPS came in at -$0.80 surpassing the estimated -$1.06 by +24.53%, while revenue for the quarter reached $92.38m , beating expectations by +6.48%.
Earnings released on 23 Feb 2022
EPS came in at -$1.10 surpassing the estimated -$1.22 by +9.84%, while revenue for the quarter reached $81.80m , beating expectations by +4.48%.
Earnings released on 4 Nov 2021
EPS came in at -$0.81 surpassing the estimated -$1.09 by +25.69%, while revenue for the quarter reached $85.43m , beating expectations by +2.24%.
Earnings released on 5 Aug 2021
EPS came in at -$0.59 surpassing the estimated -$0.97 by +39.18%, while revenue for the quarter reached $81.28m , meeting expectations.
IRTC Stock Performance
Access detailed IRTC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.